BCL2L11 and chronic myelogenous leukemia, BCR-ABL1 positive: Thus, treatments with both TKI and ABT-737 induced significantly more apoptosis than those with single agents in all primary CML cells especially in cells with the BIM deletion polymorphism where the relative increase was more than twice that of cells without the polymorphism (Figure 5A).